Having trouble accessing articles? Reset your cache.

May 31 Financial Quick Takes: Mabpharm prices Hong Kong IPO; plus follow-ons from Amicus, Myovant and more

Mabpharm down in first day of Hong Kong trading
Mabpharm Ltd. (HKSE:2181) lost HK$0.29 to HK$1.21 in its first day of trading Friday after raising HK$1.2 billion ($149.7 million) in

Read the full 292 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers